Quantitation of Total-Body Tumor Cells (MOPC 104E). I. Subcutaneous Tumor Model2

Vithal K. Ghanta; Raymond N. Hiramoto

doi:10.1093/jnci/52.4.1199

April 1, 1974JNCI Journal of the National Cancer Institute

Quantitation of Total-Body Tumor Cells (MOPC 104E). I. Subcutaneous Tumor Model2

View at Publisher

Ask AI

Bookmark

Share

Key Points

To quantify the presence of total-body tumor cells using a specific subcutaneous tumor model.
Employing MOPC 104E in a controlled subcutaneous tumor model.
Analyzing total-body tumor cell counts using established biological assays.
Significant quantification of tumor cells was achieved with the MOPC 104E model.
The findings provide insights into tumor cell distribution and behavior in vivo.

Implication

Quantifies total-body tumor cells in subcutaneous models, highlighting tumor cell behavior.

Abstract

Journal Article Quantitation of Total-Body Tumor Cells (MOPC 104E). I. Subcutaneous Tumor Model Get access Vithal K. Ghanta, Vithal K. Ghanta Search for other works by this author on: Oxford Academic PubMed Google Scholar Raymond N. Hiramoto Raymond N. Hiramoto Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 52, Issue 4, April 1974, Pages 1199–1202, https://doi.org/10.1093/jnci/52.4.1199 Published: 01 April 1974 Article history Received: 10 September 1973 Accepted: 12 December 1973 Published: 01 April 1974

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ghanta et al. (1974) studied this question.

synapsesocial.com/papers/6a070c1811ef5547c0d3bb4d https://doi.org/10.1093/jnci/52.4.1199

View at Publisher

Ask AI

Bookmark

Share

Quantitation of Total-Body Tumor Cells (MOPC 104E). I. Subcutaneous Tumor Model2

Key Points

Implication

Abstract

Discussion

Cite This Study

Quantitation of Total-Body Tumor Cells (MOPC 104E). I. Subcutaneous Tumor Model2

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading